- 20529162OWN - NLMSTAT- MEDLINEDA  - 20100720DCOM- 20110621IS  - 1540-8191 (Electronic)IS  - 0886-0440 (Linking)VI  - 25IP  - 4DP  - 2010 JulTI  - Destination therapy: patient selection and current outcomes.PG  - 462-71LID - 10.1111/j.1540-8191.2010.01050.x [doi]AB  - Long-term left-ventricular assist device (LVAD) support as destination therapy      (DT) is a promising new alternative for the growing population of patients with      advanced heart failure. In this article, we summarize the clinical trials that      led to the approval of LVAD use as DT in the US national policies regulating      candidate selection and DT center accreditation. We review current guidelines for      candidate selection, clinical tools to assess candidate operative risk, and      outcomes of DT.FAU - Lietz, KatherineAU  - Lietz KAD  - Center for Advanced Heart Failure and Transplantation, Yale University School of       Medicine, New Haven, Connecticut 06520-8017, USA. Katherine.Lietz@yale.eduLA  - engPT  - Journal ArticlePT  - ReviewDEP - 20100530PL  - United StatesTA  - J Card SurgJT  - Journal of cardiac surgeryJID - 8908809RN  - 0 (Angiotensin-Converting Enzyme Inhibitors)RN  - 0 (Antihypertensive Agents)RN  - 0 (Cardiotonic Agents)SB  - IMMH  - Angiotensin-Converting Enzyme Inhibitors/therapeutic useMH  - Antihypertensive Agents/therapeutic useMH  - Cardiotonic Agents/therapeutic useMH  - Equipment DesignMH  - Heart Failure/drug therapy/mortality/*surgeryMH  - Heart-Assist Devices/economics/*statistics & numerical dataMH  - HumansMH  - *Patient SelectionMH  - Risk FactorsMH  - Treatment OutcomeMH  - United StatesEDAT- 2010/06/10 06:00MHDA- 2011/06/22 06:00CRDT- 2010/06/10 06:00PHST- 2010/05/30 [aheadofprint]AID - JCS1050 [pii]AID - 10.1111/j.1540-8191.2010.01050.x [doi]PST - ppublishSO  - J Card Surg. 2010 Jul;25(4):462-71. doi: 10.1111/j.1540-8191.2010.01050.x. Epub      2010 May 30.